Onside Issue 6 - 13

13

Tax Advantaged
Investing with
Seneca
With over £100 million of assets under
management in our Tax Advantaged
investment products and with new
products being launched, Seneca
has rapidly emerged as one of the
UK's major players in this arena.
Announcements in the 2017 Autumn Budget
and the wider reaching Patient Capital Review
(PCR) have put the spotlight firmly on how the
UK government wishes to see the tax benefits
utilised. Having been involved in various elements
of the consultation process we are generally
positive about the outcomes.
Seneca's Business Development Director, Ian
Battersby provides an insight into the Enterprise
Investment Scheme (EIS) landscape and how
things are likely to shape up going forward.
"For quite a while now, the government's direction
of travel has been to try to ensure that when tax
reliefs are being made available they are achieving
their wider objectives and are not merely acting

Ian Battersby
Business Development Director
E ian.battersby@senecapartners.co.uk
T 01942 271 746

as a tax mitigation tool for high earners. Broadly,
the reliefs are there to encourage investment into
younger, growing companies who may otherwise
have difficulty accessing the capital they need
from traditional sources to fuel their growth. The
general principle is that tax reliefs provided on
the one hand will facilitate economic growth and
employment and come back into HM Treasury
manifold in the form of corporation tax and PAYE.
An added concern for government has been
the lack of ongoing funding for businesses over
longer periods of their growth cycles. In other
words more sustainable rather than simply short
term funding. Hence the phrase, Patient Capital.
In general terms, the wealth managers and advisory
firms who recommend Seneca products to their
clients have been accepting of EIS being investment
rather than tax-led for some considerable time
and see the income tax and capital gains tax free
benefits as icing on the cake and this is very much
the Seneca position too. Our obligation is to utilise
the vast experience and pedigree of our equity
investment team to source the most compelling
qualifying opportunities which provide the best
possible outcomes for our investors.



Table of Contents for the Digital Edition of Onside Issue 6

Contents
Onside Issue 6 - Cover1
Onside Issue 6 - Cover2
Onside Issue 6 - Contents
Onside Issue 6 - 4
Onside Issue 6 - 5
Onside Issue 6 - 6
Onside Issue 6 - 7
Onside Issue 6 - 8
Onside Issue 6 - 9
Onside Issue 6 - 10
Onside Issue 6 - 11
Onside Issue 6 - 12
Onside Issue 6 - 13
Onside Issue 6 - 14
Onside Issue 6 - 15
Onside Issue 6 - 16
Onside Issue 6 - 17
Onside Issue 6 - 18
Onside Issue 6 - 19
Onside Issue 6 - 20
Onside Issue 6 - 21
Onside Issue 6 - 22
Onside Issue 6 - 23
Onside Issue 6 - 24
Onside Issue 6 - 25
Onside Issue 6 - 26
Onside Issue 6 - 27
Onside Issue 6 - 28
Onside Issue 6 - 29
Onside Issue 6 - 30
Onside Issue 6 - 31
Onside Issue 6 - 32
Onside Issue 6 - 33
Onside Issue 6 - 34
Onside Issue 6 - 35
Onside Issue 6 - 36
Onside Issue 6 - 37
Onside Issue 6 - 38
Onside Issue 6 - 39
Onside Issue 6 - 40
Onside Issue 6 - 41
Onside Issue 6 - 42
Onside Issue 6 - 43
Onside Issue 6 - 44
Onside Issue 6 - 45
Onside Issue 6 - 46
Onside Issue 6 - Cover3
Onside Issue 6 - Cover4
https://www.nxtbookmedia.com